| Morinaga strain was originally isolated from a healthy infant and its beneficial effects have been studied extensively for thirty years.
Suppresses intestinal putrefactive bacteria by producing lactic acid, acetic acid and bacteriocins:
- Decreases count of putrefactive bacteria such as Enterobacteriaceae, Bacteroides, Clostridium, Candida, Psuedomonas and Streptococci.
Promotes regular bowel function
- Increases water content and number of Bifidobacterium in feces
Protects cellular replication:
- Reduces ACF (aberrant crypt foci) formation Supports immune system response
- Increases production of intestinal IgA and TNF-A
- Enhances T cell and macrophage activity Protects the gut from damage caused by enzymatic path
ways of intestinal pathogens:
- Decreases ammonia content by lowering certain enzymes (urease, amino acid deaminase, etc.) activities
- Reduces fecal Beta glucoronidase activity
- Lowers production of arnines and hydrogen sulfides
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
|
